News Related to Torrent Pharmaceuticals Limited

Related coverage linked through entity extraction aliases.

India’s generic semaglutide rollout shifts focus beyond price

Apr 25, 2026

Generic semaglutide launched in India as Novo Nordisk’s patent expired, with prices starting below Rs 1,300 a month. Doctors and companies said device quality, cold chains and patient support will also shape sales.

Natco Pharma Receives Approval for Generic Semaglutide in India, Launch Planned for March

Feb 13, 2026

Natco Pharma has received approval from India's CDSCO to manufacture and market generic semaglutide injection, with a March 2026 launch planned. The approval comes amid patent litigation and intense competition in India's rapidly expanding diabetes and obesity drug market.